---
title: "TAYLOR TROY T — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c19d8bd3-cdb4-5a9d-a599-88b00e64ef8d
json: https://whiteintel.dev/api/public/dossier/c19d8bd3-cdb4-5a9d-a599-88b00e64ef8d
identifier: sec:0001339276
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# TAYLOR TROY T

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001339276`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c19d8bd3-cdb4-5a9d-a599-88b00e64ef8d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c19d8bd3-cdb4-5a9d-a599-88b00e64ef8d  

## Ownership & control

### Holdings / subsidiaries

- **NRX Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/8b23f837-f8dc-5076-a308-227f50954d4d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **TAYLOR TROY T**. Human view: https://whiteintel.dev/entity/c19d8bd3-cdb4-5a9d-a599-88b00e64ef8d · Structured JSON: https://whiteintel.dev/api/public/dossier/c19d8bd3-cdb4-5a9d-a599-88b00e64ef8d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._